Literature DB >> 16126407

Estrogen rapid action via protein complex formation involving ERalpha and Src.

Robert X-D Song1, Zhenguo Zhang, Richard J Santen.   

Abstract

This review provides insight into biomolecular knowledge regarding the non-genomic actions of estrogen in hormone-dependent breast cancer, particularly its role in the rapid stimulation of pathways that transmit signals to increase cell division or decrease programmed cell death. Until recently, attention to estrogenic effects focused primarily on events in the nucleus, where most estrogen receptors (ERalpha and beta) reside. However, a fraction of ERalpha associated with the cell membrane also participates in rapid estrogen-induced cell membrane-mediated events via formation of a protein complex with many signaling molecules, leading to activation of the mitogen-activated protein kinase and Akt signaling pathways. Understanding the mechanisms underlying these relationships, with the aim of abrogating specific steps, should lead to more targeted strategies to treat hormone-dependent breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126407     DOI: 10.1016/j.tem.2005.06.010

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  55 in total

1.  Significance of ER-Src axis in hormonal therapy resistance.

Authors:  Sreeram Vallabhaneni; Binoj C Nair; Valerie Cortez; Rambabu Challa; Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Breast Cancer Res Treat       Date:  2010-12-24       Impact factor: 4.872

2.  17-Beta-estradiol-mediated activation of extracellular-signal regulated kinase, phosphatidylinositol 3-kinase/protein kinase B-Akt and N-methyl-D-aspartate receptor phosphorylation in cortical synaptoneurosomes.

Authors:  Reymundo Dominguez; Roulan Liu; Michel Baudry
Journal:  J Neurochem       Date:  2007-01-22       Impact factor: 5.372

Review 3.  Estrogen, NFkappaB, and the heat shock response.

Authors:  James P Stice; Anne A Knowlton
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 4.  Nongenomic signaling pathways of estrogen toxicity.

Authors:  Cheryl S Watson; Yow-Jiun Jeng; Mikhail Y Kochukov
Journal:  Toxicol Sci       Date:  2009-12-02       Impact factor: 4.849

5.  Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms.

Authors:  Katherine A Burns; Yin Li; Yukitomo Arao; Robert M Petrovich; Kenneth S Korach
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 6.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

7.  TGF-β Stimulation of EMT Programs Elicits Non-genomic ER-α Activity and Anti-estrogen Resistance in Breast Cancer Cells.

Authors:  Maozhen Tian; William P Schiemann
Journal:  J Cancer Metastasis Treat       Date:  2017-08-21

8.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 9.  PELP1: A novel therapeutic target for hormonal cancers.

Authors:  Dimple Chakravarty; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  IUBMB Life       Date:  2010-03       Impact factor: 3.885

10.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.